Rodriguez Louisa 4
4 · Orion Biotech Opportunities Corp. · Filed May 18, 2023
Insider Transaction Report
Form 4
Rodriguez Louisa
Director
Transactions
- Disposition to Issuer
Class B ordinary shares
2023-05-17−40,000→ 0 total→ Class A ordinary shares (40,000 underlying)
Footnotes (1)
- [F1]On April 21, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the "Articles") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by the Reporting Person were surrendered for no compensation on May 17, 2023.